MC
OGN icon

Moors & Cabot’s Organon & Co OGN Stock Holding History

Moors & Cabot’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,267
Closed -$213K – 880
2023
Q3 		$213K Sell
12,267
-2,495
-17% -$52K 0.01% 727
2023
Q2 		$307K Buy
14,762
+2,167
+17% +$47.1K 0.02% 605
2023
Q1 		$296K Sell
12,595
-349
-3% -$9.37K 0.02% 602
2022
Q4 		$362K Sell
12,944
-526
-4% -$13.4K 0.03% 516
2022
Q3 		$315K Sell
13,470
-526
-4% -$15.9K 0.02% 543
2022
Q2 		$472K Sell
13,996
-717
-5% -$25.1K 0.03% 428
2022
Q1 		$514K Buy
14,713
+591
+4% +$20.2K 0.03% 463
2021
Q4 		$430K Sell
14,122
-1,666
-11% -$54.3K 0.03% 506
2021
Q3 		$519K Sell
15,788
-146
-0.9% -$4.67K 0.03% 439
2021
Q2 		$482K Buy
+15,934
New +$525K 0.03% 433

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Moors & Cabot's OGN Position: Q4 2023 in Review

Moors & Cabot sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 12,267 shares — an estimated $213K sold.

Moors & Cabot first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $519K in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Moors & Cabot reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Moors & Cabot sold 12,267 Organon & Co shares in Q4 2023, an estimated $213K.
  • Moors & Cabot first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Moors & Cabot's Organon & Co position peaked at $519K in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Moors & Cabot's 13F filing for Q4 2023, filed 14 Feb 2024.